Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Inhibiting IGF-1 for osteoarthritis

December 16, 2024 8:47 PM UTC

Targeting cartilage IFG-1, an insulin-like growth hormone expressed downstream of WNT signaling, could help treat osteoarthritis by decreasing WNT hyperactivation-induced joint damage.

Genome-wide transcriptomic analysis of datasets from healthy human donor articular chondrocytes treated with a WNT hyperactivator tool compound, and of articular cartilage from a WNT gain-of-function mouse model, identified IGF-1 as the most upregulated gene when WNT was hyperactivated compared with normal WNT activation. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article